Raj Kumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Raj Kumar Singh has a total of 252 co-authors. Here are the top co-authors by number of shared publications:
- Vinayagamurthy Balamurugan
ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru, India
14 shared publications V. Bhanuprakash
Division of Virology, Indian Veterinary Research Institute, Campus Mukteswar, Nainital District, 263 138 Uttarakhand India ; Indian Veterinary Research Institute, Bangalore Campus, Bangalore, 560 024 Karnataka India
8 shared publications- Kuldeep Dhama
Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India
6 shared publications M. Hosamani
Indian Veterinary Research Institute, Bangalore, India
6 shared publications- Ravi Kumar Gandham
ICAR-National Bureau of Animal Genetic Resources, Karnal 132001, Haryana, India
6 shared publications Veerakyathappa Bhanuprakash
Indian Veterinary Research Institute, Bangalore, 560024 Karnataka India
6 shared publications
Latest Publications
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (2) , 137-144
One health approach in the management of gastro-intestinal parasitism in hilly terrain with reference to the animals of van Gujjar community
Pastoral transhumance is a system followed by nomadic farmers in Uttarakhand and adjoining Himalayan states, with their livelihood centered around milk and milk products. Various factors, such as extreme climatic conditions, animal diseases, nutritional deficiencies, fodder scarcity, poor herd management, and inadequate veterinary and extension services, can adversely impact the health and production of their livestock. Gastro-intestinal parasitism (GIP) is a widespread and economically significant infection in ruminants. In the transhumance hilly pastoral farming system, mortality losses due to diseases are generally lower, except in severe outbreaks of contagious disea ses. However, parasitism remains the single biggest cause of morbidity. Intelligent attention to identify various management practices is crucial for the sustainability of the transhumance pastoral farming system. Applying appropriate livestock disease management practices, with “One Health” approaches like “Good Animal Husbandry Practices (GAHPs),” f arm biosecurity, “Good Animal Grazing Practices (GAGPs),” and “Good Animal Farm Management (GAFM),” can significantly reduce the disease burden in animals, thereby minimizing the zoonotic diseases burden in humans. Achieving this goal requires proper GIP epidemiology along with anthelmintic resistance monitoring. Additionally, it is essential to validate the ethnoveterinary practices of the Van Gujjar community by employing appropriate scientific procedures.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (2) , 137-144
One health approach in the management of gastro-intestinal parasitism in hilly terrain with reference to the animals of van Gujjar community
Pastoral transhumance is a system followed by nomadic farmers in Uttarakhand and adjoining Himalayan states, with their livelihood centered around milk and milk products. Various factors, such as extreme climatic conditions, animal diseases, nutritional deficiencies, fodder scarcity, poor herd management, and inadequate veterinary and extension services, can adversely impact the health and production of their livestock. Gastro-intestinal parasitism (GIP) is a widespread and economically significant infection in ruminants. In the transhumance hilly pastoral farming system, mortality losses due to diseases are generally lower, except in severe outbreaks of contagious disea ses. However, parasitism remains the single biggest cause of morbidity. Intelligent attention to identify various management practices is crucial for the sustainability of the transhumance pastoral farming system. Applying appropriate livestock disease management practices, with “One Health” approaches like “Good Animal Husbandry Practices (GAHPs),” f arm biosecurity, “Good Animal Grazing Practices (GAGPs),” and “Good Animal Farm Management (GAFM),” can significantly reduce the disease burden in animals, thereby minimizing the zoonotic diseases burden in humans. Achieving this goal requires proper GIP epidemiology along with anthelmintic resistance monitoring. Additionally, it is essential to validate the ethnoveterinary practices of the Van Gujjar community by employing appropriate scientific procedures.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (1) , 16-25
Tick management with one health approach
Outbreaks of transboundary animal diseases (TADs), zoonotic diseases, including tick-borne diseases (TBDs), and economically significant animal diseases can cause a substantial socio-economic impact and adversely affect animal, human, and environmental health. The number of tick-borne zoonotic and non-zoonotic diseases affecting animals has significantly increased. Tick-borne diseases can be viral, bacterial (rickettsial and non-rickettsial), and protozoal. Although several attempts have been made to control these tick-borne diseases, significant challenges still remain. As these diseases occur due to multiple factors at the animal-tick-human-ecosystem interface, a one health approach is appropriate for attempting tick and tick-borne disease control. In this paper, we detail and discuss the one health concept in managing tick and tick-borne diseases in nature.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (1) , 16-25
Tick management with one health approach
Outbreaks of transboundary animal diseases (TADs), zoonotic diseases, including tick-borne diseases (TBDs), and economically significant animal diseases can cause a substantial socio-economic impact and adversely affect animal, human, and environmental health. The number of tick-borne zoonotic and non-zoonotic diseases affecting animals has significantly increased. Tick-borne diseases can be viral, bacterial (rickettsial and non-rickettsial), and protozoal. Although several attempts have been made to control these tick-borne diseases, significant challenges still remain. As these diseases occur due to multiple factors at the animal-tick-human-ecosystem interface, a one health approach is appropriate for attempting tick and tick-borne disease control. In this paper, we detail and discuss the one health concept in managing tick and tick-borne diseases in nature.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (1) , 26-36
Adopting ayurveda in health management complements “One health” approaches
The birthplace of the Ayurvedic medical system has been the Indian subcontinent. Ayurveda treats clinical disorders like sinusitis, cough, nervousness, and sleeplessness in humans by employing natural healing techniques. Ayurvedic components and medicines are also widely used in personal care items, health supplements, and some drugs for the treatment of chronic diseases. In animals, Ayurveda formulations are used as drug formulations, insecticides, pesticides, acaricides, and also as feed supplements. Increasing income, growing interest in wellness, preference for herbal products, and the availability of quality AYUSH products are driving the Ayurveda sector in India. People are choosing more and more herbal products for human use as well as animal feed and medicines. The Ayurveda market in India is expanding due to the traditions that have gained widespread acceptability for herbal remedies and Ayurvedic treatments. Growing public knowledge of the advantages of Ayurvedic products, growing incidences of chronic ailments, ease of access, affordability, expansion of medical tourism worldwide, more awareness of the negative effects of allopathy, and growing knowledge of the advantages of Ayurvedic medicines are also driving the Ayurvedic market expansion. As of now, Ayurveda remedies have been incorporated into general wellness practices world wide and, to some extent, into the medical treatment of humans and animals.
- 1 January 2023
- Published by Diva Enterprises Private Limited in Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases
- Vol. 44 (1) , 26-36
Adopting ayurveda in health management complements “One health” approaches
The birthplace of the Ayurvedic medical system has been the Indian subcontinent. Ayurveda treats clinical disorders like sinusitis, cough, nervousness, and sleeplessness in humans by employing natural healing techniques. Ayurvedic components and medicines are also widely used in personal care items, health supplements, and some drugs for the treatment of chronic diseases. In animals, Ayurveda formulations are used as drug formulations, insecticides, pesticides, acaricides, and also as feed supplements. Increasing income, growing interest in wellness, preference for herbal products, and the availability of quality AYUSH products are driving the Ayurveda sector in India. People are choosing more and more herbal products for human use as well as animal feed and medicines. The Ayurveda market in India is expanding due to the traditions that have gained widespread acceptability for herbal remedies and Ayurvedic treatments. Growing public knowledge of the advantages of Ayurvedic products, growing incidences of chronic ailments, ease of access, affordability, expansion of medical tourism worldwide, more awareness of the negative effects of allopathy, and growing knowledge of the advantages of Ayurvedic medicines are also driving the Ayurvedic market expansion. As of now, Ayurveda remedies have been incorporated into general wellness practices world wide and, to some extent, into the medical treatment of humans and animals.
- Open Access
- 11 March 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 775572
SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral pathogen causing life-threatening diseases in humans. Interaction between the spike protein of SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) is a potential factor in the infectivity of a host. In this study, the interaction of SARS-CoV-2 spike protein with its receptor, ACE2, in different hosts was evaluated to predict the probability of viral entry. Phylogeny and alignment comparison of the ACE2 sequences did not lead to any meaningful conclusion on viral entry in different hosts. The binding ability between ACE2 and the spike protein was assessed to delineate several spike binding parameters of ACE2. A significant difference between the known infected and uninfected species was observed for six parameters. However, these parameters did not specifically categorize the Orders into infected or uninfected. Finally, a logistic regression model constructed using spike binding parameters of ACE2, revealed that in the mammalian class, most of the species of Carnivores, Artiodactyls, Perissodactyls, Pholidota, and Primates had a high probability of viral entry. However, among the Proboscidea, African elephants had a low probability of viral entry. Among rodents, hamsters were highly probable for viral entry with rats and mice having a medium to low probability. Rabbits have a high probability of viral entry. In Birds, ducks have a very low probability, while chickens seemed to have medium probability and turkey showed the highest probability of viral entry. The findings prompt us to closely follow certain species of animals for determining pathogenic insult by SARS-CoV-2 and for determining their ability to act as a carrier and/or disseminator.
- 11 March 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 775572
Open AccessSARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral pathogen causing life-threatening diseases in humans. Interaction between the spike protein of SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) is a potential factor in the infectivity of a host. In this study, the interaction of SARS-CoV-2 spike protein with its receptor, ACE2, in different hosts was evaluated to predict the probability of viral entry. Phylogeny and alignment comparison of the ACE2 sequences did not lead to any meaningful conclusion on viral entry in different hosts. The binding ability between ACE2 and the spike protein was assessed to delineate several spike binding parameters of ACE2. A significant difference between the known infected and uninfected species was observed for six parameters. However, these parameters did not specifically categorize the Orders into infected or uninfected. Finally, a logistic regression model constructed using spike binding parameters of ACE2, revealed that in the mammalian class, most of the species of Carnivores, Artiodactyls, Perissodactyls, Pholidota, and Primates had a high probability of viral entry. However, among the Proboscidea, African elephants had a low probability of viral entry. Among rodents, hamsters were highly probable for viral entry with rats and mice having a medium to low probability. Rabbits have a high probability of viral entry. In Birds, ducks have a very low probability, while chickens seemed to have medium probability and turkey showed the highest probability of viral entry. The findings prompt us to closely follow certain species of animals for determining pathogenic insult by SARS-CoV-2 and for determining their ability to act as a carrier and/or disseminator.
- Open Access
Immunization with Brucella abortus S19Δper Conferred Protection in Water Buffaloes against Virulent Challenge with B. abortus Strain S544
Vaccination of cattle and buffaloes with Brucella abortus strain 19 has been the mainstay for control of bovine brucellosis. However, vaccination with S19 suffers major drawbacks in terms of its safety and interference with serodiagnosis of clinical infection. Brucella abortus S19∆per, a perosamine synthetase wbkB gene deletion mutant, overcomes the drawbacks of the S19 vaccine strain. The present study aimed to evaluate the potential of Brucella abortus S19Δper vaccine candidate in the natural host, buffaloes. Safety of S19∆per, for animals use, was assessed in guinea pigs. Protective efficacy of vaccine was assessed in buffaloes by immunizing with normal dose (4 × 1010 colony forming units (CFU)/animal) and reduced dose (2 × 109 CFU/animal) of S19Δper and challenged with virulent strain of B. abortus S544 on 300 days post immunization. Bacterial persistency of S19∆per was assessed in buffalo calves after 42 days of inoculation. Different serological, biochemical and pathological studies were performed to evaluate the S19∆per vaccine. The S19Δper immunized animals showed significantly low levels of anti-lipopolysaccharides (LPS) antibodies. All the immunized animals were protected against challenge infection with B. abortus S544. Sera from the majority of S19Δper immunized buffalo calves showed moderate to weak agglutination to RBPT antigen and thereby, could apparently be differentiated from S19 vaccinated and clinically-infected animals. The S19Δper was more sensitive to buffalo serum complement mediated lysis than its parent strain, S19. Animals culled at 6-weeks-post vaccination showed no gross lesions in organs and there was comparatively lower burden of infection in the lymph nodes of S19Δper immunized animals. With attributes of higher safety, strong protective efficacy and potential of differentiating infected from vaccinated animals (DIVA), S19Δper would be a prospective alternate to conventional S19 vaccines for control of bovine brucellosis as proven in buffaloes.
Open AccessImmunization with Brucella abortus S19Δper Conferred Protection in Water Buffaloes against Virulent Challenge with B. abortus Strain S544
Vaccination of cattle and buffaloes with Brucella abortus strain 19 has been the mainstay for control of bovine brucellosis. However, vaccination with S19 suffers major drawbacks in terms of its safety and interference with serodiagnosis of clinical infection. Brucella abortus S19∆per, a perosamine synthetase wbkB gene deletion mutant, overcomes the drawbacks of the S19 vaccine strain. The present study aimed to evaluate the potential of Brucella abortus S19Δper vaccine candidate in the natural host, buffaloes. Safety of S19∆per, for animals use, was assessed in guinea pigs. Protective efficacy of vaccine was assessed in buffaloes by immunizing with normal dose (4 × 1010 colony forming units (CFU)/animal) and reduced dose (2 × 109 CFU/animal) of S19Δper and challenged with virulent strain of B. abortus S544 on 300 days post immunization. Bacterial persistency of S19∆per was assessed in buffalo calves after 42 days of inoculation. Different serological, biochemical and pathological studies were performed to evaluate the S19∆per vaccine. The S19Δper immunized animals showed significantly low levels of anti-lipopolysaccharides (LPS) antibodies. All the immunized animals were protected against challenge infection with B. abortus S544. Sera from the majority of S19Δper immunized buffalo calves showed moderate to weak agglutination to RBPT antigen and thereby, could apparently be differentiated from S19 vaccinated and clinically-infected animals. The S19Δper was more sensitive to buffalo serum complement mediated lysis than its parent strain, S19. Animals culled at 6-weeks-post vaccination showed no gross lesions in organs and there was comparatively lower burden of infection in the lymph nodes of S19Δper immunized animals. With attributes of higher safety, strong protective efficacy and potential of differentiating infected from vaccinated animals (DIVA), S19Δper would be a prospective alternate to conventional S19 vaccines for control of bovine brucellosis as proven in buffaloes.
- Open Access
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 8
Proteome Modulation in Peripheral Blood Mononuclear Cells of Peste des Petits Ruminants Vaccinated Goats and Sheep
In the present study, healthy goats and sheep (n= 5) that were confirmed negative forpeste des petitsruminants virus (PPRV) antibodies by monoclonal antibody-based competitive ELISA and by serum neutralization test and for PPRV antigen by s-ELISA were vaccinated with Sungri/96. A quantitative study was carried out to compare the proteome of peripheral blood mononuclear cells (PBMCs) of vaccinated goat and sheep [5 days post-vaccination (dpv) and 14 dpv] vs. unvaccinated (0 day) to divulge the alteration in protein expression following vaccination. A total of 232 and 915 proteins were differentially expressed at 5 and 14 dpv, respectively, in goats. Similarly, 167 and 207 proteins were differentially expressed at 5 and 14 dpv, respectively, in sheep. Network generated by Ingenuity Pathway Analysis was “infectious diseases, antimicrobial response, and inflammatory response,” which includes the highest number of focus molecules. The bio functions, cell-mediated immune response, and humoral immune response were highly enriched in goats at 5 dpv and at 14 dpv. At the molecular level, the immune response produced by the PPRV vaccine virus in goats is effectively coordinated and stronger than that in sheep, though the vaccine provides protection from virulent virus challenge in both. The altered expression of certain PBMC proteins especially ISG15 and IRF7 induces marked changes in cellular signaling pathways to coordinate host immune responses.
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 8
Open AccessProteome Modulation in Peripheral Blood Mononuclear Cells of Peste des Petits Ruminants Vaccinated Goats and Sheep
In the present study, healthy goats and sheep (n= 5) that were confirmed negative forpeste des petitsruminants virus (PPRV) antibodies by monoclonal antibody-based competitive ELISA and by serum neutralization test and for PPRV antigen by s-ELISA were vaccinated with Sungri/96. A quantitative study was carried out to compare the proteome of peripheral blood mononuclear cells (PBMCs) of vaccinated goat and sheep [5 days post-vaccination (dpv) and 14 dpv] vs. unvaccinated (0 day) to divulge the alteration in protein expression following vaccination. A total of 232 and 915 proteins were differentially expressed at 5 and 14 dpv, respectively, in goats. Similarly, 167 and 207 proteins were differentially expressed at 5 and 14 dpv, respectively, in sheep. Network generated by Ingenuity Pathway Analysis was “infectious diseases, antimicrobial response, and inflammatory response,” which includes the highest number of focus molecules. The bio functions, cell-mediated immune response, and humoral immune response were highly enriched in goats at 5 dpv and at 14 dpv. At the molecular level, the immune response produced by the PPRV vaccine virus in goats is effectively coordinated and stronger than that in sheep, though the vaccine provides protection from virulent virus challenge in both. The altered expression of certain PBMC proteins especially ISG15 and IRF7 induces marked changes in cellular signaling pathways to coordinate host immune responses.
- Open Access
- 27 April 2021
- Published by American Society for Microbiology in mSystems
- Vol. 6 (2)
Systems Biology behind Immunoprotection of Both Sheep and Goats after Sungri/96 PPRV Vaccination
Immune response is a highly coordinated cascade involving all the subsets of peripheral blood mononuclear cells (PBMCs). In this study, RNA sequencing (RNA-Seq) analysis of PBMC subsets was done to delineate the systems biology behind immune protection of the vaccine in sheep and goats. The PBMC subsets studied were CD4+, CD8+, CD14+, CD21+, and CD335+ cells from day 0 and day 5 of sheep and goats vaccinated with Sungri/96 peste des petits ruminants virus. Assessment of the immune response processes enriched by the differentially expressed genes (DEGs) in all the subsets suggested a strong dysregulation toward the development of early inflammatory microenvironment, which is very much required for differentiation of monocytes to macrophages, and activation as well as the migration of dendritic cells into the draining lymph nodes. The protein-protein interaction networks among the antiviral molecules (IFIT3, ISG15, MX1, MX2, RSAD2, ISG20, IFIT5, and IFIT1) and common DEGs across PBMC subsets in both species identified ISG15 to be a ubiquitous hub that helps in orchestrating antiviral host response against peste des petits ruminants virus (PPRV). IRF7 was found to be the key master regulator activated in most of the subsets in sheep and goats. Most of the pathways were found to be inactivated in B lymphocytes of both the species, indicating that 5 days postvaccination (dpv) is too early a time point for the B lymphocytes to react. The cell-mediated immune response and humoral immune response pathways were found more enriched in goats than in sheep. Although animals from both species survived the challenge, a contrast in pathway activation was observed in CD335+ cells. IMPORTANCE Peste des petits ruminants (PPR) by PPR virus (PPRV) is an World Organisation for Animal Health (OIE)-listed acute, contagious transboundary viral disease of small ruminants. The attenuated Sungri/96 PPRV vaccine used all over India against this PPR provides long-lasting robust innate and adaptive immune response. The early antiviral response was found mediated through type I interferon-independent interferon-stimulated gene (ISG) expression. However, systems biology behind this immune response is unknown. In this study, in vivo transcriptome profiling of PBMC subsets (CD4+, CD8+, CD14+, CD21+, and CD335+) in vaccinated goats and sheep (at 5 days postvaccination) was done to understand this systems biology. Though there are a few differences in the systems biology across cells (specially the NK cells) between sheep and goats, the coordinated response that is inclusive of all the cell subsets was found to be toward the induction of a strong innate immune response, which is needed for an appropriate adaptive immune response.
- 27 April 2021
- Published by American Society for Microbiology in mSystems
- Vol. 6 (2)
Open AccessSystems Biology behind Immunoprotection of Both Sheep and Goats after Sungri/96 PPRV Vaccination
Immune response is a highly coordinated cascade involving all the subsets of peripheral blood mononuclear cells (PBMCs). In this study, RNA sequencing (RNA-Seq) analysis of PBMC subsets was done to delineate the systems biology behind immune protection of the vaccine in sheep and goats. The PBMC subsets studied were CD4+, CD8+, CD14+, CD21+, and CD335+ cells from day 0 and day 5 of sheep and goats vaccinated with Sungri/96 peste des petits ruminants virus. Assessment of the immune response processes enriched by the differentially expressed genes (DEGs) in all the subsets suggested a strong dysregulation toward the development of early inflammatory microenvironment, which is very much required for differentiation of monocytes to macrophages, and activation as well as the migration of dendritic cells into the draining lymph nodes. The protein-protein interaction networks among the antiviral molecules (IFIT3, ISG15, MX1, MX2, RSAD2, ISG20, IFIT5, and IFIT1) and common DEGs across PBMC subsets in both species identified ISG15 to be a ubiquitous hub that helps in orchestrating antiviral host response against peste des petits ruminants virus (PPRV). IRF7 was found to be the key master regulator activated in most of the subsets in sheep and goats. Most of the pathways were found to be inactivated in B lymphocytes of both the species, indicating that 5 days postvaccination (dpv) is too early a time point for the B lymphocytes to react. The cell-mediated immune response and humoral immune response pathways were found more enriched in goats than in sheep. Although animals from both species survived the challenge, a contrast in pathway activation was observed in CD335+ cells. IMPORTANCE Peste des petits ruminants (PPR) by PPR virus (PPRV) is an World Organisation for Animal Health (OIE)-listed acute, contagious transboundary viral disease of small ruminants. The attenuated Sungri/96 PPRV vaccine used all over India against this PPR provides long-lasting robust innate and adaptive immune response. The early antiviral response was found mediated through type I interferon-independent interferon-stimulated gene (ISG) expression. However, systems biology behind this immune response is unknown. In this study, in vivo transcriptome profiling of PBMC subsets (CD4+, CD8+, CD14+, CD21+, and CD335+) in vaccinated goats and sheep (at 5 days postvaccination) was done to understand this systems biology. Though there are a few differences in the systems biology across cells (specially the NK cells) between sheep and goats, the coordinated response that is inclusive of all the cell subsets was found to be toward the induction of a strong innate immune response, which is needed for an appropriate adaptive immune response.
- Open Access
Systems Biology behind immunoprotection of both Sheep and Goats after Sungri/96 PPRV vaccination
Immune response is a highly coordinated cascade involving all the subsets of PBMCs. In this study, RNA-Seq analysis of PBMC subsets - CD4+, CD8+, CD14+, CD21+ and CD335+ cells from day 0 and day 5 of Sungri/96 Peste des Petits Ruminants vaccinated sheep and goats was done to delineate the systems biology behind immune - protection of the vaccine in sheep and goats. Assessment of the immune response processes enriched by the differentially expressed genes in all the subsets suggested a strong dysregulation towards development of early inflammatory microenvironment, which is very much required for differentiation of monocytes to macrophages, and for activation and migration of dendritic cells into the draining lymph nodes. The protein - protein interaction networks among the antiviral molecules (IFIT3, ISG15, MX1, MX2, RSAD2, ISG20, IFIT5 and IFIT1) and common DEGs across PBMCs subsets in both the species identified ISG15 to be an ubiquitous hub, that helps in orchestrating antiviral host response against PPRV. IRF7 was found to be the key master regulator activated in most of the subsets in sheep and goats. Most of the pathways were found to be inactivated in B - lymphocytes of both the species indicating that 5 dpv is too early a time point for the B - lymphocytes to react. The cell mediated immune response and humoral immune response pathways were found more enriched in goats than in sheep. Though, animals from both the species survived the challenge, a contrast in pathway activation was observed in CD335+ cells. Importance: Peste des petits ruminants (PPR) by PPRV is an OIE listed acute, contagious transboundary viral disease of small ruminants. Attenuated Sungri/96 PPRV vaccine used all over India against this PPR, provides long-lasting robust innate and adaptive immune response. The early antiviral response was found mediated through type I interferon independent ISGs expression. However, systems biology behind this immune response is unknown. In this study, in vivo transcriptome profiling of PBMC subsets (CD4+, CD8+, CD14+, CD21+ and CD335+) in vaccinated goats and sheep (at 5 days of post vaccination) was done to understand this systems biology. Though there are a few differences in the systems biology across cells (specially the NK cells) between sheep and goats, the co-ordinated response that is inclusive of all the cell subsets was found to be towards induction of strong innate immune response, which is needed for an appropriate adaptive immune response.
Open AccessSystems Biology behind immunoprotection of both Sheep and Goats after Sungri/96 PPRV vaccination
Immune response is a highly coordinated cascade involving all the subsets of PBMCs. In this study, RNA-Seq analysis of PBMC subsets - CD4+, CD8+, CD14+, CD21+ and CD335+ cells from day 0 and day 5 of Sungri/96 Peste des Petits Ruminants vaccinated sheep and goats was done to delineate the systems biology behind immune - protection of the vaccine in sheep and goats. Assessment of the immune response processes enriched by the differentially expressed genes in all the subsets suggested a strong dysregulation towards development of early inflammatory microenvironment, which is very much required for differentiation of monocytes to macrophages, and for activation and migration of dendritic cells into the draining lymph nodes. The protein - protein interaction networks among the antiviral molecules (IFIT3, ISG15, MX1, MX2, RSAD2, ISG20, IFIT5 and IFIT1) and common DEGs across PBMCs subsets in both the species identified ISG15 to be an ubiquitous hub, that helps in orchestrating antiviral host response against PPRV. IRF7 was found to be the key master regulator activated in most of the subsets in sheep and goats. Most of the pathways were found to be inactivated in B - lymphocytes of both the species indicating that 5 dpv is too early a time point for the B - lymphocytes to react. The cell mediated immune response and humoral immune response pathways were found more enriched in goats than in sheep. Though, animals from both the species survived the challenge, a contrast in pathway activation was observed in CD335+ cells. Importance: Peste des petits ruminants (PPR) by PPRV is an OIE listed acute, contagious transboundary viral disease of small ruminants. Attenuated Sungri/96 PPRV vaccine used all over India against this PPR, provides long-lasting robust innate and adaptive immune response. The early antiviral response was found mediated through type I interferon independent ISGs expression. However, systems biology behind this immune response is unknown. In this study, in vivo transcriptome profiling of PBMC subsets (CD4+, CD8+, CD14+, CD21+ and CD335+) in vaccinated goats and sheep (at 5 days of post vaccination) was done to understand this systems biology. Though there are a few differences in the systems biology across cells (specially the NK cells) between sheep and goats, the co-ordinated response that is inclusive of all the cell subsets was found to be towards induction of strong innate immune response, which is needed for an appropriate adaptive immune response.